Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
City of Hope Medical Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
NeoImmuneTech
AstraZeneca
I-Mab Biopharma US Limited
Merck Sharp & Dohme LLC
Sotio Biotech Inc.
Alaunos Therapeutics
Incyte Corporation
National Cancer Institute (NCI)
Elicio Therapeutics
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
Incyte Corporation
Sichuan Enray Pharmaceutical Sciences Company
Institut Bergonié
NGM Biopharmaceuticals, Inc
Numab Therapeutics AG
M.D. Anderson Cancer Center
Elevation Oncology
UNC Lineberger Comprehensive Cancer Center
Stanford University
BeiGene
Lokon Pharma AB
Sellas Life Sciences Group
Mundipharma Research Limited
Rain Oncology Inc
Pfizer
NantCell, Inc.
NantCell, Inc.
Pfizer
NextCure, Inc.
ADC Therapeutics S.A.
Cancer Research and Biostatistics Clinical Trials Consortium
Exelixis
Pfizer
Tesaro, Inc.
Pfizer
Children's Oncology Group
University Hospital, Ghent
pharmaand GmbH
M.D. Anderson Cancer Center
Hoffmann-La Roche
City of Hope Medical Center
OncoNano Medicine, Inc.
Revolution Medicines, Inc.
Fred Hutchinson Cancer Center